24.159.1477 CIRCUMSTANCES CONSTITUTING A LOW RISK OF ADVERSE HOMEBIRTH OUTCOMES (1) A low risk of adverse birth outcomes indicates a clinical scenario for which there is not clear demonstratable benefit for a medical intervention or transfer to a physician's care. (2) Consultation with a physician does not preclude a low risk of adverse birth outcomes. (3) Preexisting arrangements for emergency transportation to a nearby hospital if needed do not preclude a low risk of adverse birth outcomes. (4) The following conditions preclude a low risk of adverse birth outcomes. (a) Pre-existing conditions (not gynecological): (i) subarachnoid hemorrhage, aneurysm; (ii) recent or acute herniated nucleus pulposus; (iii) active tuberculosis or ongoing treatment; (iv) human immunodeficiency virus, acquired immunodeficiency syndrome, hepatitis B or hepatitis C; (v) heart defect with hemodynamic consequences; (vi) clotting disorders; (vii) kidney dysfunction; (viii) hypertension; (ix) diabetes mellitus; (x) unmedicated thyroid disorders with present TSH receptor antibodies; (xi) inflammatory bowel disease, including ulcerative colitis and Crohn's disease; (xii) systemic and rare disorders, including Addison's disease, Cushing's syndrome, systemic lupus erythematosus, antiphospholipid syndrome, scleroderma, rheumatoid arthritis, polyarteritis nodosa, Raynaud's disease, and Marfan syndrome; (xiii) illegal drug use; or (xiv) alcoholism. (b) Pre-existing gynecological conditions: (i) pelvic floor reconstruction; (ii) conization; (iii) myomectomy or other uterine surgery; or (iv) uterine distortion, including bicornuate, septate, unicornuate, or didelphic conditions. (c) Obstetric history: (i) blood group antagonism, including Rhesus, Kell, Duffy, and Kidd glycoproteins; (ii) previous pre-term (before 34 weeks) birth. If a normal pregnancy occurred after the premature birth, the current birth may be considered to be low risk; (iii) cervical insufficiency or cerclage; (iv) placental abruption; (v) caesarean section - must transfer current pregnancy at 37 weeks if no reason for transfer prior; (vi) dysmaturity; (vii) uncontrolled post-partum hemorrhage; (viii) manual placental removal; (ix) placenta accreta; and (x) total uterine rupture with no functional recovery; or (xi) history of intrauterine fetal demise. (d) Occurring or diagnosed during pregnancy: (i) rubella; (ii) cytomegalovirus; (iii) genital herpes (primo infection); (iv) parvovirus; (v) tuberculosis; (vi) human immunodeficiency virus or acquired immunodeficiency syndrome; (vii) syphilis; (viii) illegal drug use; (ix) alcoholism; (x) maternal anemia; (xi) extrauterine pregnancy; (xii) amniotic fluid loss or preterm labor before 37 weeks; (xiii) uncontrolled diabetes mellitus; (xiv) gestational diabetes mellitus; (xv) gestational hypertension with diastolic blood pressure above 100 or systolic blood pressure above 160; (xvi) preeclampsia, superimposed preeclampsia, hemolysis, or elevated liver enzymes and low platelets (HELLP) syndrome; (xvii) blood group antagonism; (xviii) deep vein thrombosis; (xix) clotting disorders; (xx) vasa previa; (xxi) velamentous cord insertion; (xxii) placenta previa; (xxiii) placental abruption; (xxiv) serotonin syndrome; (xxv) cervical insufficiency prior to 37 weeks of gestation; (xxvi) multiple pregnancy; (xxvii) breech or abnormal position at term; or (xxviii) fetal mortality; or (xxix) prolonged gestation > 42 weeks.
History: 37-1-131, MCA; IMP, 37-8-202, MCA; NEW, 2023 MAR p. 1561, Eff. 11/4/23. |